 |
인쇄하기
취소
|
Hepatitis B therapy ‘Virea’ sold for more than KRW 100 billion in 9 months
The collective sales of the Yuhan Corporation’s hepatitis B treatment ‘Viread’ by the last September were aggregated to exceed KRW 100 billion.
According to Yuhan Corporation, its 2016 third quarter’s collective sales were KRW 971.04 billion, increased by 17.6% compared to the same period of the last year.
It was analyzed its goods sales and merchandise sales were KRW 421.5 billion and KRW 53...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.